Cesario Alfredo, Auffray Charles, Russo Patrizia, Hood Leroy
Director, Area of Systems Medicine, IRCCS San Raffaele Pisana, Rome, Italy.
Curr Pharm Des. 2014;20(38):6071-2. doi: 10.2174/1381612820666140314145445.
This monographic issue of Current Pharmacological Design discusses extensively on the innovative paradigms for disease control in Active and Healthy Ageing. Wellness, as a status to be achieved and maintained in our lives, getting longer and hopefully healtier, is the new and comprehensive declination of "health" itself, leading the shaping of research and research policy in the health domain worldwide. Many of the contributions describe the state of the art -and beyond- approaches for the most common diseases based on the available medical knowledge; two, in particular (Bousquet J et al., Cesario A, et al.), extend to the innovative approaches defined in the framework of the holistic and integrative philosophy of the Predictive, Preventive, Personalized and Participatory (P4) Systems Medicine. The availability of more and more powerful technologies to extract data coupled with the inclusion of information coming from the nonstrictly-medical sphere of the patient/individual and his/her lifestyle along with the increase in computational power, will definitely set the stage for a paradigm-shift in bio-medicine with deep ethical and societal impact. The brief comment that follows speculates about the implications of this transition from the educational perspective taking stock of the direct experience of the Authors in the consultation process active in the scientific community.
本期《当代药物设计》专题深入探讨了积极健康老龄化中疾病控制的创新模式。健康作为我们在日益长寿且有望更加健康的生活中要实现和维持的一种状态,是“健康”本身新的全面定义,引领着全球健康领域研究及研究政策的形成。许多文章基于现有医学知识描述了针对最常见疾病的最新及前沿方法;其中两篇文章(分别由布索凯·J等人、切萨里奥·A等人撰写)特别探讨了在预测、预防、个性化和参与性(P4)系统医学的整体综合理念框架内所定义的创新方法。越来越强大的数据提取技术,加上纳入来自患者/个体非严格医学领域及其生活方式的信息,以及计算能力的提升,必将为生物医学带来范式转变,产生深刻的伦理和社会影响。以下简短评论从教育角度推测了这一转变的影响,总结了作者在科学界积极参与的咨询过程中的直接经验。
Curr Pharm Des. 2014
J Frailty Aging. 2017
Geriatr Gerontol Int. 2015-6
Biotechnol J. 2012-7-20
Ann Ist Super Sanita. 2017
Arch Bronconeumol. 2010-12-28
Int Microbiol. 2012-6
Front Med (Lausanne). 2022-1-25
J Pers Med. 2021-4-19
Open Access Maced J Med Sci. 2019-9-14
Front Immunol. 2018-11-16
Database (Oxford). 2018-1-1
Eur Respir Rev. 2018-2-7